Search

Your search keyword '"Chim CS"' showing total 166 results

Search Constraints

Start Over You searched for: "Chim CS" Remove constraint "Chim CS" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years Publisher nature publishing group uk Remove constraint Publisher: nature publishing group uk
166 results on '"Chim CS"'

Search Results

6. Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

8. Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells

9. The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

10. Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

13. Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

16. Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index

23. Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma

24. Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma

26. Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis

28. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

31. Selective elimination of immunosuppressive T cells in patients with multiple myeloma

32. Copy number evolution and its relationship with patient outcome—an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

38. A simple additive staging system for newly diagnosed multiple myeloma

41. A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group

47. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

49. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

50. Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

Catalog

Books, media, physical & digital resources